UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053253
Receipt number R000060773
Scientific Title Effect of peripheral-central arterial pressure gradient after cardiopulmonary bypass on postoperative management in cardiovascular surgery
Date of disclosure of the study information 2024/01/02
Last modified on 2023/12/31 14:46:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of peripheral-central arterial pressure gradient after cardiopulmonary bypass on postoperative management in cardiovascular surgery

Acronym

Effect of peripheral-central arterial pressure gradient after cardiopulmonary bypass on postoperative management in cardiovascular surgery

Scientific Title

Effect of peripheral-central arterial pressure gradient after cardiopulmonary bypass on postoperative management in cardiovascular surgery

Scientific Title:Acronym

Effect of peripheral-central arterial pressure gradient after cardiopulmonary bypass on postoperative management in cardiovascular surgery

Region

Japan


Condition

Condition

heart disease

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The primary hypothesis is that "patients with a peripheral central artery pressure gradient at the time of cardiopulmonary withdrawal require a higher dose of catecholamine postoperatively than those without a peripheral central artery pressure gradient at the time of cardiopulmonary withdrawal".

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A peripheral central artery pressure gradient is defined as a difference of 10 mmHg in mean blood pressure and 25 mmHg or more in systolic blood pressure for more than 5 minutes at the time of cardiopulmonary withdrawal, and postoperative catecholamine use and length of ICU stay are compared.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Adult cardiovascular surgical procedures performed at our facility between April 1, 2021 and March 31, 2023 that involve the use of cardiac pulmonary bypass.

Key exclusion criteria

Cases in which it was impossible to secure the radial artery line, cases in which there was originally a peripheral-central arterial pressure gradient due to arterial stenosis, and other cases deemed inappropriate by the investigator.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Yamada

Organization

Chiba university hospital

Division name

Department of Anesthesiology, Pain and Palliative Care Medicine

Zip code

2608677

Address

1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan

TEL

+81-43-226-2303

Email

tyamada_violine@yahoo.co.jp


Public contact

Name of contact person

1st name Takayuki
Middle name
Last name Yamada

Organization

Chiba university hospital

Division name

Department of Anesthesiology, Pain and Palliative Care Medicine

Zip code

2608677

Address

1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan

TEL

+81-43-226-2303

Homepage URL


Email

tyamada_violine@yahoo.co.jp


Sponsor or person

Institute

Chiba university

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba university hospital

Address

1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan

Tel

+81-43-226-2303

Email

tyamada_violine@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

323

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 06 Month 20 Day

Date of IRB

2023 Year 07 Month 03 Day

Anticipated trial start date

2024 Year 01 Month 02 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Because of the large number of research subjects in this study and the extremely large amount of time and expense involved in obtaining their consent, information about this study will be made public and research subjects will be given the opportunity to refuse to participate in this study. If a research subject refuses to participate in this research, the subject will not be included in this research, unless the research results have already been published in an article or other publication at the time the refusal is made.
The following information will be posted in places where research subjects can be identified and on websites, etc., and will be readily available to research subjects.


Management information

Registered date

2023 Year 12 Month 31 Day

Last modified on

2023 Year 12 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060773


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name